TAAT:CC - TAAT Global Alternatives, Inc. Signs Definitive Agreement to Acquire Premium Products LLC
(TheNewswire)
Vancouver, BC, January 27,2025 – TheNewswire - TAAT Global Alternatives, Inc. ( CSE: TAAT )( OTCQX: TOBAF ) ( FRANKFURT:2TP ) (the “Company” or “TAAT”) announcesthat it has entered into a binding definitive agreement with PremiumProducts LLC (“Premium Products”) dated January 27, 2025, underwhich TAAT will acquire a 100% equity interest in Premium Products. Pursuant to theJanuary 17, 2025 announcement of entering into a non-binding Letter ofIntent, the Company conducted due diligence, finalized negotiationsand documented the framework of an acquisition transaction. Thetransaction is anticipated to close in early February 2025 and issubject to all shareholders of Premium Products (the"Vendors") agreeing to be bound by the definitive agreement,and to applicable filings with the Canadian Securities Exchange (the“CSE”).
Premium Products is an emerging distributor in thealternative product space. This acquisition aligns with TAAT’sstrategic objectives to diversify its product offerings, tap into newmarket opportunities, and accelerate revenue growth within theconsumer-packaged goods (CPG) sector. Premium Products have a diverseproduct portfolio through its Delta-9 offerings which includechocolates, gummies, and disposable vape devices. Premium Productshave also developed partnerships to bring other innovative products tomarket, including non-tobacco nicotine alternatives andwellness-focused beverages, reinforcing its position in thealternative product space.
Consideration for theacquisition of Premium Products will be 10,882,353 common shares ofthe Company issued at a deemed price of $0.17 per share (the“Consideration Shares”). The Consideration Shares will be subjectto the statutory four (4) month and one (1) day hold period fromissuance. Upon completion of the transaction, Premium Products willoperate as a wholly owned subsidiary of TAAT. The Vendors arearm’s-length parties to the Company.
No finder’s fees will be payable in connection withthe closing of the acquisition.
None of the securities issued in connection with theacquisition of Premium Products will be registered under the UnitedStates Securities Act of 1933, as amended (the “1933 Act”), andnone of them will be offered or sold in the United States absentregistration or an applicable exemption from the registrationrequirements of the 1933 Act. This news release shall not constitutean offer to sell or a solicitation of an offer to buy nor shall therebe any sale of the securities in any state where such offer,solicitation, or sale would be unlawful.
The acquisition remainssubject to receipt of all necessary regulatory approvals, including,as applicable, all required filings with the Canadian SecuritiesExchange. The acquisition will not constitute a fundamental change,within the meaning of the policies of the CSE.
TAAT’s Continued Organic Growth
TAAT continues to experience demand for its BeyondTobacco™ cigarettes, which provide a nicotine- and tobacco-freesmoking experience. This trend reflects broader consumer preferencesfor wellness-focused alternatives, particularly among adult smokersseeking healthier options. The acquisition enhances TAAT’s abilityto deliver a broader range of alternative products to meet evolvingconsumer demands.
On behalf of the Board of Directors of theCompany,
TAAT® GLOBAL ALTERNATIVES INC.
“Joel Dumaresq”
Joel Dumaresq, CFO and Director
For further information, please contact:
TAAT® Investor Relations
1-604-687-2038
investor@taatglobal.com
THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOTREVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY ORADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATIONSERVICES PROVIDER.
AboutTAAT Global Alternatives, Inc.
TAAT is a consumer product company specializing ininnovative alternatives to traditional CPG categories. With acommitment to quality and consumer satisfaction, TAAT operates fromits Ohio distribution center, fulfilling orders and supporting agrowing network of retail locations across the U.S.
For additional information, visit taatglobal.com
Forward-Looking Statements
Certain information contained herein may constitute"forward-looking information" or "forward-lookingstatements" under Canadian securities legislation. Generally,forward- looking information can be identified bywords such as "pro forma", "plans","expects", "may", "should","could", "will", "budget","scheduled", "estimates", "forecasts","intends", "anticipates", "believes", orvariations including negative variations thereof of such words andphrases that refer to certain actions, events or results that may,occur or be taken or achieved. Such forward-looking statements,including but not limited to statements relating to the expecteddevelopment and operations of the Company, including marketconditions, regulatory developments and the successful integration andperformance of Premium Products LLC within TAAT’s broader operationswhich involve risks, uncertainties and other factors which may causethe actual results to be materially different from those expressed orimplied by such forward-looking statements or forward-lookinginformation. There can be no assurance that such statements will proveto be accurate, as actual results and future events could differmaterially from those anticipated in such statements. Accordingly,readers should not place undue reliance on forward-looking statementsand forward-looking information. The Corporation will not update anyforward-looking statements or forward-looking information includedherein, except as required by applicable securities laws.
The statements in this news release have not beenevaluated by Health Canada or the U.S. Food and Drug Administration.As each individual is different, the benefits, if any, of taking theCompany’s products will vary from person to person. No claims orguarantees can be made as to the effects of the Company’s productson an individual’s health and well-being. The Company’s productsare not intended to diagnose, treat, cure, or prevent anydisease.
This news release may contain trademarked names ofthird-party entities (or their respective offerings with trademarkednames) typically in reference to (i) relationships had by the Companywith such third-party entities as referred to in this release and/or(ii) client/vendor/service provider parties whose relationship withthe Company is/are referred to in this release. All rights to suchtrademarks are reserved by their respective owners orlicensees.
Statement Regarding Third-PartyInvestor Relations Firms
Disclosures relating to investor relations firmsretained by TAAT® Global Alternatives Inc. can be found under theCompany's profile on www.sedarplus.ca .
Copyright (c) 2025 TheNewswire - All rights reserved.